Stockreport

Unum Therapeutics Presents Preclinical Data for BOXR1030 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

UNUM THERAPEUTICS INC COMMON  (UMRX) 
Last unum therapeutics inc common earnings: 3/26 07:30 am Check Earnings Report
PDF - Unum’s first product candidate from its BOXR platform, BOXR1030, is designed to improve T cell functionality in the solid tumor microenvironment -           - BOXR103 [Read more]